Foghorn Therapeutics Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €19.50M -33.8% -€74.72M -12.0% -383.2% -0.95 pp -€85.83M -14.9% -440.2% -0.98 pp
    €29.46M +77.6% -€84.90M -9.6% -288.2% +2.8 pp -€100.82M -160.0% -342.2% -14 pp
    €16.59M +1,357.8% -€93.91M +5.5% -566.2% +73 pp €168.05M -515.1% 1,013.2% +46 pp
    €1.14M +206.7% -€89.04M +47.9% -7,826.1% +84 pp -€40.49M +210.8% -3,558.5% -0.46 pp
    €370.91K +∞% -€60.19M +35.1% -16,227.7% -160 pp -€13.03M -66.7% -3,512.3% -35 pp
    €0.00 +NaN% -€44.57M +96.2% N/A -€39.13M +114.9% N/A
    €0.00 -€22.72M N/A -€18.21M N/A

    Notifications